Copyright
©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 787-795
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.787
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.787
Diseases/status | SUA level | UA production | Focus 1 | UA excresion | Focus 2 |
T2DM | High/low | ||||
Glucosuria | Low | Up | Glomerulus | ||
Insulin resistance | High | Down | Proximal tubule cell | ||
Use of SGLT2 inhibitor | Low | Up | |||
Retinopathy | Up | Vitreus | |||
MetS | High | Up | Adipocyte/liver? | Down | Proximal tubule cell |
CKD | High | Up | Vascular endothelial cell/inflammatory cell | Down/up | Kidney/intestine |
Hypertension | High | Up | |||
Atherosclerosis | Up | Vascular endothelial cell/inflammatory cell | |||
Reperfusion injury | Up | Vascular endothelial cell | |||
Heart failure | Up | Inflammatory cell | |||
Fructose intake | High | Up | Liver | Down | |
Sodium intake | High | Down | |||
Thiazide administration | High | Down | Proximal tubule cell |
- Citation: Kushiyama A, Tanaka K, Hara S, Kawazu S. Linking uric acid metabolism to diabetic complications. World J Diabetes 2014; 5(6): 787-795
- URL: https://www.wjgnet.com/1948-9358/full/v5/i6/787.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i6.787